-
Recent Posts
Recent Comments
Archives
- October 2012
- December 2011
- November 2011
- September 2011
- March 2011
- December 2010
- November 2010
- September 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- November 2009
- October 2009
- September 2009
- July 2009
- June 2009
- February 2009
- January 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
- December 2006
- November 2006
- October 2006
- August 2006
- April 2006
- March 2006
- December 2005
- November 2005
- July 2005
- March 2005
- February 2005
- January 2005
- December 2004
- November 2004
- October 2004
- September 2004
- August 2004
Categories
Meta
Monthly Archives: October 2008
Safety of biological agents
We draw our readers attention to an interesting paper examining European and US regualtory actions concerned with the safety of the new wave of biological agents published in JAMA. The full text is free.
Posted in ADRs
Comments Off
Rimonabant (Accomplia®) withdrawal
Rimonabant’s marketing licence has been suspended by the Eurpean Medicines Evaluation Agency because of an increased risk of psychiatric disorders, and concerns about its effectiveness: Following the assessment of the available information on the benefits and risks of Acomplia including … Continue reading